The growth of new blood capillaries from existing vessels (angiogenesis) is essential for development, tissue regeneration and remodeling. Angiogenesis also contributes to pathologic conditions including diabetic retinopathy and tumor growth, and anti-angiogenesis strategies are under clinical evaluation. Angiogenesis is a multi-step process involving endothelial cell proliferation, migration, and tube formation. Vascular Endothelial Growth Factor (VEGF) is a critical pro-angiogenic factor that stimulates multiple endothelial cell activities through binding to its receptor KDR. The long term goal of our research is clarify the signaling pathways that mediate these responses and to understand how the pathways are coordinated. VEGF-induced cell proliferation in mediated by the ERK1/2 MAPKinase. The signaling pathway leading to ERK1/2 activation involves the sequential activation of PLCg and PKC; this is unique when compared to many other growth factors which utilize Grb2 and Ras . VEGF-induced ERK1/2 activation is also dependent upon the generation of reactive oxygen species (ROS). The molecular interactions by which VEGF-induced ROS generation is coordinated with the PLCg-PKC pathway are not known; although our recent experimental results implicate the involvement of the SHP-1 protein tyrosine phosphatase. Experimental results that led to this conclusion include the finding that inhibition of SHP-1 by a dominant negative strategy mimics the effect of VEGF on ERK1/2 activation. We propose to validate this conclusion, and to further clarify VEGF-induced signaling mechanisms involved in cell proliferation by proposing three Specific Aims.
AIM 1 is directed at clarifying SHP-1's role in neovascularization using an in vivo model; more specifically, vascular development in the mouse retina.
AIM 2 is directed at further clarifying the molecular interactions involved in SHP-1 function by identifying SHP-1 substrates.
AIM 3 is directed at clarifying the molecular interactions by which VEGF treatment modulates SHP-1 catalytic activity. Upon completion of these studies we will have clarified the earliest signaling events involved in VEGF-induced cell proliferation. The results obtained will be important in understanding how new blood vessels are formed, and will perhaps suggest new strategies for blocking pathological angiogenesis. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA086289-06A1
Application #
6986310
Study Section
Cardiovascular Differentiation and Development Study Section (CDD)
Program Officer
Macleod, Carol L
Project Start
1999-08-16
Project End
2010-04-30
Budget Start
2005-07-01
Budget End
2006-04-30
Support Year
6
Fiscal Year
2005
Total Cost
$315,563
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Hiroyasu, Shungo; Chinnasamy, Prameladevi; Hou, Rong et al. (2013) Donor and recipient cell surface colony stimulating factor-1 promote neointimal formation in transplant-associated arteriosclerosis. Arterioscler Thromb Vasc Biol 33:87-95
Hou, Rong; Sibinga, Nicholas E S (2009) Atrophin proteins interact with the Fat1 cadherin and regulate migration and orientation in vascular smooth muscle cells. J Biol Chem 284:6955-65
Sibinga, Nicholas E S (2009) Stable protein, unstable plaque? J Mol Cell Cardiol 46:289-91
Kim, Mee-Ohk; Suh, Hyeon-Sook; Si, Qiusheng et al. (2006) Anti-CD45RO suppresses human immunodeficiency virus type 1 replication in microglia: role of Hck tyrosine kinase and implications for AIDS dementia. J Virol 80:62-72
Hotchkiss, Kylie A; Basile, Cheryl M; Spring, Simone C et al. (2005) TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res 305:133-44
Tao, Qi; Spring, Simone C; Terman, Bruce I (2005) Comparison of the signaling mechanisms by which VEGF, H2O2, and phosphatase inhibitors activate endothelial cell ERK1/2 MAP-kinase. Microvasc Res 69:36-44
Stoletov, Konstantin V; Terman, Bruce I (2004) Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation. Biochem Biophys Res Commun 320:70-5
Stoletov, Konstantin V; Gong, Chunhong; Terman, Bruce I (2004) Nck and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover and integrin activation. Exp Cell Res 295:258-68
Gong, Chunhong; Stoletov, Konstantin V; Terman, Bruce I (2004) VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization. Angiogenesis 7:313-21
Tao, Qi; Spring, Simone C; Terman, Bruce I (2003) Characterization of a new alternatively spliced neuropilin-1 isoform. Angiogenesis 6:39-45

Showing the most recent 10 out of 13 publications